Macias RIR - Search Results

1

Serum Metabolites as Diagnostic Biomarkers for Cholangiocarcinoma, Hepatocellular Carcinoma, and Primary Sclerosing Cholangitis.

Banales JM, Iñarrairaegui M, Arbelaiz A, Milkiewicz P, Muntané J, Muñoz-Bellvis L, La Casta A, Gonzalez LM, Arretxe E, Alonso C, Martínez-Arranz I, Lapitz A, Santos-Laso A, Avila MA, Martínez-Chantar ML, Bujanda L, Marin JJG, Sangro B, Macias RIR. Banales JM, et al. Among authors: macias rir. Hepatology. 2019 Aug;70(2):547-562. doi: 10.1002/hep.30319. Epub 2019 Feb 14. Hepatology. 2019. PMID: 30325540 Free PMC article.

2

Relationship between bile acid transplacental gradients and transport across the fetal-facing plasma membrane of the human trophoblast.

Monte MJ, Rodriguez-Bravo T, Macias RI, Bravo P, el-Mir MY, Serrano MA, Lopez-Salva A, Marin JJ. Monte MJ, et al. Pediatr Res. 1995 Aug;38(2):156-63. doi: 10.1203/00006450-199508000-00004. Pediatr Res. 1995. PMID: 7478809

3

Reversible impairment of neonatal hepatobiliary function by maternal cholestasis.

Monte MJ, Morales AI, Arevalo M, Alvaro I, Macias RI, Marin JJ. Monte MJ, et al. Hepatology. 1996 May;23(5):1208-17. doi: 10.1002/hep.510230540. Hepatology. 1996. PMID: 8621155

4

Rat liver transport and biotransformation of a cytostatic complex of bis-cholylglycinate and platinum (II).

Marin JJ, Herrera MC, Palomero MF, Macias RI, Monte MJ, El-Mir MY, Villanueva GR. Marin JJ, et al. J Hepatol. 1998 Mar;28(3):417-25. doi: 10.1016/s0168-8278(98)80315-2. J Hepatol. 1998. PMID: 9551679

5

Comparison of the effects of bischolylglycinatechloro-platinum(II) versus cisplatin on liver regeneration after partial hepatectomy.

Herrera MC, Palomero MF, Macias RI, Serrano MA, Marin JJ. Herrera MC, et al. Anticancer Res. 1998 Sep-Oct;18(5A):3555-63. Anticancer Res. 1998. PMID: 9858939

6

Cholephilic characteristics of a new cytostatic complex of cisplatin with glycocholate (Bamet-R2).

Macias RI, El-Mir MY, Monte MJ, Serrano MA, Garcia MJ, Marin JJ. Macias RI, et al. J Control Release. 1999 Feb 1;57(2):161-9. doi: 10.1016/s0168-3659(98)00114-x. J Control Release. 1999. PMID: 9971896

7

Further evidence of the usefulness of bile acids as molecules for shuttling cytostatic drugs toward liver tumors.

Monte MJ, Dominguez S, Palomero MF, Macias RI, Marin JJ. Monte MJ, et al. J Hepatol. 1999 Sep;31(3):521-8. doi: 10.1016/s0168-8278(99)80046-4. J Hepatol. 1999. PMID: 10488713

8

Effect of maternal cholestasis on bile acid transfer across the rat placenta-maternal liver tandem.

Macias RI, Pascual MJ, Bravo A, Alcalde MP, Larena MG, St-Pierre MV, Serrano MA, Marin JJ. Macias RI, et al. Hepatology. 2000 Apr;31(4):975-83. doi: 10.1053/he.2000.5921. Hepatology. 2000. PMID: 10733555

9

Overcoming cisplatin resistance in vitro by a free and liposome-encapsulated bile acid derivative: BAMET-R2.

Briz O, Serrano MA, Macias RI, Marin JJ. Briz O, et al. Int J Cancer. 2000 Oct 15;88(2):287-92. Int J Cancer. 2000. PMID: 11004682

10

Low in vivo toxicity of a novel cisplatin-ursodeoxycholic derivative (Bamet-UD2) with enhanced cytostatic activity versus liver tumors.

Dominguez MF, Macias RI, Izco-Basurko I, de La Fuente A, Pascual MJ, Criado JM, Monte MJ, Yajeya J, Marin JJ. Dominguez MF, et al. J Pharmacol Exp Ther. 2001 Jun;297(3):1106-12. J Pharmacol Exp Ther. 2001. PMID: 11356935

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

138 results

Search Page

Filters